FDA Investigator Kerun Hardeo
Kerun Hardeo has inspections in 1 countries as of 12 Dec 2023. Kerun Hardeo has collaborated with a combined 741 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
20
Last Inspection Date:
12 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alice S Tsao,
Amy W Yan Mai,
Andrew B Paglia, DPM,
Benton M Ketron,
Bernardica T Sculac Stern,
Brandy D Brown,
Byungja E Marciante,
Charisse K Green,
D Jenny Argiropoulos,
Daniel Green,
Demitria J Xiradakis,
Dr. Mark J Seaton, PhD,
Evelyn Taha,
Gifford Whitehurst, Jr,
Helen B Ricalde,
Iram R Hassan, PhD,
Irina Gaberman,
Jacqueline S Warner,
Jana J Lau,
Joanne M Schlossin,
Jonathan D Green,
Joy P Matthias,
Leena Thomas,
Lisa Mathew,
Matthew A Spalazo,
Matthew A Spataro,
Michael R Dominick,
Michael Serrano,
Omadevi Somai, Investigator,
Paul Mouris,
S Thomas,
Sabine Francke,
Satheesh Thomas,
Sheri L Stephenson,
Simone E Pitts,
State Agency,
Tara K Carmody,
Thomas P Hansen,
Uduak M Inokon,
Valerie J Grecek Trinh,
Wai H Lam,
Yuyan Liang
Kerun Hardeo's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2022 | FDA 483 | Columbia University Medical Center IRB - Form 483, 2022-08-31 |
May, 2022 | FDA 483 | NYC Health + Hospitals/Bellevue - Form 483, 2022-05-06 |
December, 2022 | FDA 483 | Jack Michael Mann, M.D. - Form 483, 2022-12-06 |
September, 2022 | FDA 483 | Memorial Sloan Kettering Cancer Center - Form 483, 2022-09-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more